Cancer Immunotherapy Market Size, Growth 2019 Share, Merger, Trends, Statistics, Regional Analysis, Key Players, And Global Forecast To 2023

Jul 2, 2019

Cancer Immunotherapy Market Analysis 2019 to 2023 report published by “Market Research Future”. According to report Global Cancer Immunotherapy Market to Rise At 12.5% CAGR by 2023. Cancer Immunotherapy by Type of Therapy, Application, End Use, region with Forecast To 2023.

Pune, India - July 2, 2019 /MarketersMedia/ —

Cancer Immunotherapy Market Analysis 2019 to 2023 report published by “Market Research Future”. According to report Global Cancer Immunotherapy Market to Rise At 12.5% CAGR by 2023. Cancer Immunotherapy Industry report anlayzes Market for Cancer Immunotherapy by Type of Therapy (Monoclonal Antibodies, Adoptive Cell Transfer and others), Application (Lung Cancer, Childhood Cancer and other), End User (Hospitals, Clinics & others), region with Forecast To 2023.

Major Cancer Immunotherapy Companies covered in the market report include Merck & Co., Inc., F. Hoffmann-La Roche AG, Novartis International AG, Amgen Inc., GlaxoSmithKline Plc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, Seattle Genetics, Inc., and Spectrum Pharmaceuticals, Inc.

Get Free Sample "Cancer Immunotherapy Market Research - Global Forecast till 2023" report at: https://www.marketresearchfuture.com/sample_request/567

Global Cancer Immunotherapy Market Highlights:

Global cancer immunotherapy market has been growing at a impressive rate in recent years and will maintain the same in coming future. Due to deteriorating lifestyle, smoking, and alcoholism are responsible for increasing the incidence of cancer. Increasing cancer population is the major reason for increasing the global immunotherapy market.

The global cancer immunotherapy market is growing pervasively and will continue so in the years to come mainly due to the growing prevalence of cancer. Though cancer is no more considered as a deadly disease, there still exist around 100 different types of cancer which are prevailing. Changing lifestyle is a key risk factor of these various types of cancers.

Additional factors such as rising adverse effects, such as recurrence of cancer and organ failure, associated with conventional chemotherapies are fostering the market growth. Increasing R&D activities, clinical trials, and new approvals are fueling the growth of the market. Companies are collaborating with independent research centers and hospitals to bring novelties into therapies which are acting as major driving forces for the market.

The rapid uptake of this therapy by medical professionals as well as patients and increasing success rate are some of the dominant factors driving the market growth. The cancer immunotherapy market is flourishing, especially in emerging economies and the demand for advanced cancer immunotherapy is estimated to rise soon.

On the other hand, lack of awareness and adverse effects associated with immune therapeutic drugs are projected to impede the growth of the cancer immunotherapy market. Nevertheless, increasing number of immunotherapeutic drug classes, especially the target receptors for multiple myeloma and checkpoint inhibitors will support the market growth.

Global Cancer Immunotherapy Market Segments:

MRFR has segmented its analysis into four Key dynamics for an easy grasp;

By Types of Therapy: Monoclonal Antibodies (naked monoclonal antibodies, conjugated monoclonal antibodies, and bispecific monoclonal antibodies.), Cytokines (Interferon, Interleukins, and others), Treatment Vaccines, Bacillus Calmette-Guérin, and Adoptive Cell Transfer among others.

By Applications: Liver Cancer, Childhood Cancer, Colorectal Cancer, Stomach Cancer, and Lung Cancer among others.

By End-Users: Hospitals and Clinics among others.

By Regions: Europe, North America, APAC and the Rest-of-the-World.

Regional Analysis:

The North American region dominates the global cancer immunotherapy market. The market growth is majorly supported by the radiotherapy market in the US which is growing due to the large patient pool and substantial healthcare expenditures.

Furthermore, the increasing prevalence of types of cancer and thyroid fuelled by the consequences of the wrong lifestyle fosters the market growth in the region. Moreover, factors such as technological advancement and well-spread awareness among people towards the benefits of this therapy support market growth.

The cancer immunotherapy market in the European region is rapidly emerging as another lucrative market owing to the increasing number of cancer patients in the region. Furthermore, the proliferation of advanced treatment facilities alongside the availability of skilled medical professionals, and the government support for research & development drives the market in the region.

The Asia Pacific region accounts for another promising market for the cancer immunotherapy. Factors substantiating market growth include the increasing prevalence of cancer, spreading awareness among people about cancer, and the availability of new treatment methods. Proliferating markets in China and India majorly contribute to the market growth in the region.

The cancer immunotherapy market in the Middle East and Africa region is expected to witness slow growth due to the lack of awareness of the chronic diseases and the limited treatment facilities in these regions.

TABLE OF CONTENTS:

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Cancer Immunotherapy Market, By Therapy Type

6.1 Introduction

6.2 Monoclonal Antibodies

6.2.1 Market Estimates & Forecast, 2017-2023

6.3 Adoptive Cell Transfer

6.3.1 Market Estimates & Forecast, 2017-2023

6.4 Cytokines

6.4.1 Interferon (INFs)

6.4.2 Interleukins (ILs)

6.4.3 Market Estimates & Forecast, 2017-2023

6.5 Treatment Vaccines

6.5.1 Market Estimates & Forecast, 2017-2023

6.6 Bacillus Calmette-Guérin

6.6.1 Market Estimates & Forecast, 2017-2023

6.7 Others

7. Global Cancer Immunotherapy Market, By Application

7.1 Introduction

7.2 Liver Cancer

7.2.1 Market Estimates & Forecast, 2017-2023

7.3 Childhood Cancer

7.3.1 Market Estimates & Forecast, 2017-2023

7.4 Colorectal Cancer

7.4.1 Market Estimates & Forecast, 2017-2023

7.5 Stomach Cancer

7.5.1 Market Estimates & Forecast, 2017-2023

7.6 Lung Cancer

7.6.1 Market Estimates & Forecast, 2017-2023

7.7 Others

Continued...

LIST OF TABLES:

Table 1 Cancer Immunotherapy Industry Synopsis, 2017-2023

Table 2 Global Cancer Immunotherapy Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global Cancer Immunotherapy Market By Region, 2017-2023, (USD Million)

Table 4 Global Cancer Immunotherapy Market By Therapy Therapy Types, 2017-2023, (USD Million)

Table 5 Global Cancer Immunotherapy Market By Application, 2017-2023, (USD Million)

Table 6 Global Cancer Immunotherapy Market By End Users, 2017-2023, (USD Million)

Table 7 North America Cancer Immunotherapy Market By Therapy Therapy Types, 2017-2023, (USD Million)

Table 8 North America Cancer Immunotherapy Market By Application, 2017-2023, (USD Million)

Table 9 North America Cancer Immunotherapy Market By End Users, 2017-2023, (USD Million)

Table 10 U.S. Cancer Immunotherapy Market By Therapy Types, 2017-2023, (USD Million)

Continued...

LIST OF FIGURES:

FIGURE 1 Research Process Of MRFR

FIGURE 2 Top-Down & Bottom-Up Approach

FIGURE 3 Market Dynamics

FIGURE 4 Impact Analysis: Market Drivers

FIGURE 5 Impact Analysis: Market Restraints

FIGURE 6 Porter's Five Forces Analysis

FIGURE 7 Value Chain Analysis

Continued...

Browse More Information On This Report at: https://www.marketresearchfuture.com/reports/global-cancer-immunotherapy-market-567

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: abhishek sawant
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528,, Amanora Chambers Magarpatta Road, Pune, India.,
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/global-cancer-immunotherapy-market-567

Source URL: https://marketersmedia.com/cancer-immunotherapy-market-size-growth-2019-share-merger-trends-statistics-regional-analysis-key-players-and-global-forecast-to-2023/88892133

Source: MarketersMedia

Release ID: 88892133

More News

Kelana Jaya Line LRT service resumes after temporary disruption

Kelana Jaya Line LRT service resumes after temporary disruption

Oct 15, 2024

KUALA LUMPUR: The Kelana Jaya Line LRT service between the Wangsa Maju and Gombak stations fully resumed operation at 3.30 pm today after repair works were completed, says Rapid Rail Sdn Bhd. The Rapid KL rail service operator previously stated that the service disruption was caused by an unusual flow of rainwater in the surrounding area, which entered the tracks and damaged several track components at around 10.20 am. Rapid Rail said that the operations team was forced to cut off the power supply in the affected area to allow for inspections and repair works. “The Rapid Rail engineering team has successfully completed temporary repair works on the track components. Tests on the system and track components were also conducted to ensure that services could resume safely in accordance with safety standards. “However, the engineering and operations teams will continue to monitor the system’s stability to ensure smooth train operations,“ the statement said. Rapid Rail thanked passengers for their patience throughout the service disruption. Several roads in Kuala Lumpur were flooded following continuous heavy rain that began around 9 am today.

Elderly woman in Penang rescued from garbage-infested house

Elderly woman in Penang rescued from garbage-infested house

Oct 15, 2024

PETALING JAYA: An elderly woman was rescued from her home, which was piled in heaps of rubbish, making it difficult for her to leave her residence . The Penang Civil Defence Force was deployed to the 86-year-old’s house on Monday (Oct 14) at 4.40pm after responding to her family members’ call for help, the New Straits Times reported. She was reportedly carried out on a stretcher during the operation. ALSO READ: Perak govt to aid retired teacher with hoarding disorder Her family claimed that the woman, living alone, was not in good health, riddled with “hypertension and hearing problems”, on top of her “frail” condition, as quoted. Not only that, her family members claim that she would call for help late at night as she is also “prone to falls”, as quoted. “As such, her family wants to send her to an old folk’s home after obtaining her consent,” he was quoted as saying. ALSO READ: Ipoh City Council clears three tonnes of garbage from elderly woman’s home Civil Defence Force northeast district officer, Muhammad Aizat Abdul Ghani confirmed that the double-storey house located in Jalan Mano was filled with so much rubbish and recyclable materials amassed over the years. Her house was not only filled with rubbish indoors but outdoors as well. The elderly woman said she hired help to clean her house but claims they never showed up.

GISBH: KPWKM prioritises swift reunification of rescued children with families

GISBH: KPWKM prioritises swift reunification of rescued children with families

Oct 15, 2024

KUALA LUMPUR: The immediate return of children rescued during Op Global to their parents and families is a top priority for the Ministry of Women, Family and Community Development (KPWKM). However, its minister, Datuk Seri Nancy Shukri said KPWKM must first ensure that the children’s parents and families can provide adequate and proper care. “For cases where the capability of the parents and families is clearly established, the reunification process can proceed without delay. In more complex situations, intervention programmes will be implemented to ensure the children’s and families’ best interests are safeguarded “The ultimate goal is to reunite these children with their families. However, before this can happen, several factors need to be carefully evaluated. This is not about denying anyone’s rights, but about ensuring the best interests of the children are upheld,” Nancy said during a minister’s briefing session on GISB Holdings Sdn Bhd (GISBH) in the Dewan Rakyat today. As of yesterday, 560 children – 283 boys and 277 girls – had been placed in safe custody after the Social Welfare Department (JKM) obtained a temporary court custody order for two months under Section 25(2)(a) of the Child Act 2001. Meanwhile, Nancy said the Task Force Profiling Team for Op Global found that 94.3 per cent of the 558 profiled children had at least one living biological parent, while 5.7 per cent had no parents or no available information on their parents. Health assessments showed that 51.6 per cent of the children were underweight, falling below the healthy Body Mass Index (BMI), while 46.1 per cent had a normal weight and the remaining children were classified as obese, she added. “Three children have been issued persons with disabilities (PwD) cards, while 27 others display symptoms of disability,” she added. Cognitive assessments were also conducted on 385 children aged seven and above, with 71.9 per cent (277 children) showing no signs of cognitive disorders, she said. “However, 20.26 per cent (78 children) displayed moderate cognitive disorders, while 7.79 per cent (30 children) were found to have severe cognitive impairments,” Nancy said.

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Oct 15, 2024

PETALING JAYA: A surprise inspection by Johor Public Works, Transport, Infrastructure, and Communications committee chairman, Mohamad Fazli Mohamad Salleh recently found 17 Immigration counters at the Johor checkpoint empty. The inspection was conducted following a video circulating online showing the 17 empty counters at the checkpoint in Sultan Abu Bakar Complex (KSAB), triggering public backlash. He confirmed that the surprise inspection found that the incident actually occurred, Harian Metro reported. The video showed the empty counters, with green lights on however, the pathways were closed off to commuters. ALSO READ: Woman calls out Immigration officer for alleged rude behaviour Fazli then instructed that the green lights to be turned off to indicate that the lane is closed, to ensure no one is confused. “If there is no solid reason given regarding the incident, this can be considered intentional,” he was quoted as saying. On the other hand, Johor Immigration director Datuk Mohd Rusdi Mohd Darus said an internal probe will be conducted on the incident. ALSO READ: Woman expresses gratitude to Johor Immigration officers for returning lost RM1.5k “The internal investigation will determine whether the immigration officer handling the counter neglected their duties or intentionally left the counter without permission. “We will not tolerate this behaviour, and strict disciplinary action will be taken against them if they are found to have neglected their duties. “It is a violation of responsibility, and I take this issue seriously,“ he was quoted as saying.

Police have started investigating companies linked to GISBH overseas - Saifuddin Nasution

Police have started investigating companies linked to GISBH overseas - Saifuddin Nasution

Oct 15, 2024

KUALA LUMPUR: The police (PDRM) have initiated investigations into companies linked to GISB Holdings Sdn Bhd (GISBH), which are operating overseas. Home Minister Datuk Seri Saifuddin Nasution Ismail acknowledged the challenges of extending investigations beyond Malaysia’s borders but confirmed that PDRM have already reached out to authorities in 18 countries where these companies are believed to be active. “The police have taken steps to contact these countries using mutual legal agreements (MLA) to facilitate cooperation,” he said during a briefing on the GISBH issue at the Dewan Rakyat today. Earlier reports indicated that PDRM had identified 23 properties owned by GISBH in 10 countries, with an estimated value RM52.4 million. Saifuddin Nasution also said that 15 cases have been brought before courts nationwide, with trial dates pending. He highlighted a case of child abuse linked to the investigation, where the accused pleaded guilty and received a 10-year prison sentence. “There have been numerous breaches of the law, and it is imperative that we conduct the investigation thoroughly and with full accountability, allowing the legal process to unfold as it should. “I want to make it clear that there is no political motive behind the government’s handling of this case. The fact remains, crimes against children have occurred,” he said.

Malaysia should seize opportunity in global medical devices market - Chang

Malaysia should seize opportunity in global medical devices market - Chang

Oct 15, 2024

KUALA LUMPUR: Malaysian innovators and manufacturers should seize the opportunity to tap into the immense potential of the global medical devices industry, which is projected to reach nearly US$800 billion by 2030, says Science, Technology and Innovation (MOSTI) Minister Chang Lih Kang. Chang noted that Malaysia had many high-quality products and innovators in the medical devices sector, with the government continuously encouraging and supporting industry players in research and development (R&D) and commercialisation efforts. “The market is vast, and we have plenty of room for success. To support R&D, of course, not limited to the medical devices industry, MOSTI offers various funding facilities, grants, matching grants, and equity where we invest in relevant startups,” he said. Chang said this to reporters after officiating the soft launch of INNOMed: Innovation Pitching Powered by PERANTIM, a key event in the International Medical Device Exhibition & Conference (IMDEC) 2024. Also present were Medical Device Authority (MDA) chief executive officer Dr P. Muralitharan, Malaysia Medical Devices Manufacturers Association (PERANTIM) president Johari Abu Kasim, and organising chairman of INNOMed, Dr Hyzan Mohd Yusof. Earlier in his speech, Chang said that under Malaysia’s New Industrial Master Plan (NIMP) 2030, the government aimed to foster synergies between the manufacturing and engineering sectors and the medical devices sector. This includes creating advanced inspection tools, solutions for imaging and endoscopy, implantable devices, and minimally invasive surgical tools. Meanwhile, Muralitharan told Bernama that, according to figures from the Department of Statistics Malaysia (DOSM), Malaysia’s total trade in medical devices, valued at RM25.61 billion from January to July this year, increased by 23.5 per cent compared to the same period in 2023 (RM20.74 billion). He added that the export of medical devices was valued at RM20.15 billion, an increase of 25.7 per cent compared to RM16.02 billion in 2023. In his speech, Dr Hyzan said that medical device innovation presented an opportunity to improve healthcare while boosting the economy, with the industry projected to reach nearly US$2 billion by 2025, making it one of the fastest-growing sectors. “By focusing on innovation, we can create high-skilled jobs, reduce our dependence on imported technologies, and position Malaysia as a global leader. Last year, we spent US$5 billion on medical devices, with 95 per cent being imports. Our goal is to reduce this to 50 per cent within five years,” he said. He also emphasised that close collaboration among universities, innovators, manufacturers, clinicians, and government agencies was key to ensuring that ideas and research transitioned smoothly from laboratories to clinical applications and into the hands of healthcare providers. INNOMed, themed “Unleashing the Power of Medical Technology: Shaping the Future of Healthcare,“ is organised by the MDA and will take place from Dec 10 to 12 at the Kuala Lumpur Convention Centre (KLCC).

Recommended

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Utara Selatan

Bringing you from Utara to Selatan, we publish travel guides to make sure you will discover new places to visit in Malaysia and try all the local delicacies.

ABOUT US
Newsletter

Copyright © 2015 - 2026 Utara Selatan. All Rights Reserved.